Exchange: NASDAQ·Updated 07:30 PM EDT

RLYB Rallybio Corp

$16.81
$0.05
(0.30%)
Today
Closed $16.81
$0.00
(0.00%)
After Hours
Reported EarningsNov 6
Mkt Cap$89.27M
Vol5,762.00

About RLYB

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
49

Neutral Sentiment

How do you feel about RLYB?

Advertisement|Remove ads.